Picture of Accuray logo

ARAY Accuray Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapTurnaround

Momentum

Relative Strength (%)
1m-2.89%
3m-5.96%
6m-0.6%
1yr-42.66%
Volume Change (%)
10d/3m-17.36%
Price vs... (%)
52w High-34.1%
50d MA+6.96%
200d MA+1.14%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)40.3
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.47
Price to Tang. Bookn/a
Price to Free Cashflown/a
Price to Sales0.46
EV to EBITDA138.57

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-1.42%
Return on Equity-41.76%
Operating Margin-0.87%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202530th Jun 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Accuray EPS forecast chart

Profile Summary

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Directors

Last Annual
June 30th, 2024
Last Interim
September 30th, 2024
Incorporated
February 22nd, 2001
Public Since
February 8th, 2007
No. of Shareholders
165
No. of Employees
987
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
100,565,016

ARAY Share Price Performance

Upcoming Events for ARAY

Q2 2025 Accuray Inc Earnings Release

Q3 2025 Accuray Inc Earnings Release

Similar to ARAY

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

Picture of Align Technology logo

Align Technology

us flag iconNASDAQ Global Select Market

Picture of Alphatec Holdings logo

Alphatec Holdings

us flag iconNASDAQ Global Select Market

Picture of Angiodynamics logo

Angiodynamics

us flag iconNASDAQ Global Select Market

FAQ